8-K/A

AMENDMENT TO FORM 8-K

Company: Silo Pharma, Inc.
Filed: February 12, 2021
Period of Report: February 9, 2021
Accession Number: 0001213900-21-009075

View Document ↗ View on SEC.gov ↗